Clinical Trial Update: Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction

View source ↗

Summary

A clinical trial evaluating matrix metalloproteinase activation after acute myocardial infarction was withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: Yale University | Conditions: Acute Myocardial Infarction | Status: WITHDRAWN